Avalo Therapeutics Inc

NASDAQ:AVTX   11:05:28 AM EDT
4.98
-0.09 (-1.78%)
Earnings Announcements

Avalo Reports Q2 Loss Per Share Of $1.38

Published: 08/04/2022 12:28 GMT
Avalo Therapeutics Inc (AVTX) - Avalo Reports Second Quarter 2022 Financial Results and Provides Business Updates.
Avalo Therapeutics Inc - Qtrly Loss per Share $1.38.
Revenue is expected to be $1.26 Million
Adjusted EPS is expected to be -$0.88

Next Quarter Revenue Guidance is expected to be $5.33 Million
Next Quarter EPS Guidance is expected to be -$0.69

More details on our Analysts Page.